“Cost/effectiveness model of dabigatran in the prevention of venous thromboembolism in major orthopedic surgery: Adaptation for Italy” (2010) Farmeconomia. Health economics and therapeutic pathways, 11(2), pp. 91–101. doi:10.7175/fe.v11i2.183.